Conexeu Sciences Inc. Common Stock (CNXU) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Conexeu Sciences Inc. Common Stock (CNXU) has a cash flow conversion efficiency ratio of -0.251x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.80 Million) by net assets ($7.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Conexeu Sciences Inc. Common Stock market capitalisation for the company's overall valuation and market capitalisation.
Conexeu Sciences Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2024–2025)
This chart illustrates how Conexeu Sciences Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Conexeu Sciences Inc. Common Stock stock quote for real-time trading data and today's change.
Conexeu Sciences Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Conexeu Sciences Inc. Common Stock ranked by their cash flow conversion efficiency. Review Conexeu Sciences Inc. Common Stock financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ruentex Materials Co Ltd
TW:8463
|
0.186x |
|
Swelect Energy Systems Limited
NSE:SWELECTES
|
0.069x |
|
STIF Société anonyme
PA:ALSTI
|
-0.068x |
|
Hites S.A.
SN:HITES
|
0.166x |
|
Vranken-Pommery Monopole Société Anonyme
PA:VRAP
|
-0.107x |
|
Akfen Yenilenebilir Enerji A.S.
IS:AKFYE
|
0.050x |
|
Tsang Yow Industrial Co Ltd
TW:1568
|
0.033x |
|
Tah Kong Chemical Industrial
TWO:4706
|
0.003x |
Annual Cash Flow Conversion Efficiency for Conexeu Sciences Inc. Common Stock (2024–2025)
The table below shows the annual cash flow conversion efficiency of Conexeu Sciences Inc. Common Stock from 2024 to 2025. Also see CNXU current and non-current assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | $7.35 Million | $-1.67 Million | -0.227x | +90.43% |
| 2024-10-31 | $94.96K | $-225.44K | -2.374x | -- |
About Conexeu Sciences Inc. Common Stock
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, b… Read more